Cryptosporidium Diagnostic Testing Market 2027 by Type, Application, Mode of Action | The Insight Partners

Cryptosporidium Diagnostic Testing Market Forecast to 2027 - Covid-19 Impact and Global Analysis - by Type (Acid-staining Test, Stool Culture, Others); Application (Hospitals, Commercial and Private Labs, Physician Offices, Public Health Labs); Mode of Action (Cytotoxic, Neurotoxic, Haemotoxic, Cardiotoxic, Myotoxic, Others (If Any))

Report Code: TIPRE00008503 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
Covid
MARKET INTRODUCTION

Cryptosporidiosis is a diarrheal disease caused by microscopic parasites named "Cryptosporidium" that lives in the intestine of humans and animals. Both parasites and diseases are usually called "Crypto." The outer shell of the parasite offers protection and allows it to persist outside the body for a long time. This outer layer also makes it flexible to chlorine-based disinfectants.

MARKET DYNAMICS

The cryptosporidium diagnostic testing market is anticipated to grow by an increase in infections caused by water-borne diseases, mandatory laws by the government to check water quality and purity, and a rise in the importance of water testing activities in many verticals of the industry. However, the high cost and availability of products in specific regions are restraining market growth. Moreover, factors such as climate change, which alters the quality or supply of water, rise in demand for rapid diagnostic tests, innovation in techniques to develop better diagnostic assays, increase in geriatric population is expected to benefit the growth of the market in the forecast period.

MARKET SCOPE

The "Cryptosporidium Diagnostic Testing Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of in cryptosporidium diagnostic testing market with detailed market segmentation by type, application, mode of action and geography. The cryptosporidium diagnostic testing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in cryptosporidium diagnostic testing market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The cryptosporidium diagnostic testing market is segmented on the basis of type, application and mode of action. Based on type the market is segmented as acid-staining test, stool culture and others. On the basis of application the market is categorized as hospitals, commercial and private labs, physician offices and public health labs. On the basis of mode of action the market is categorized as cytotoxic, neurotoxic, haemotoxic, cardiotoxic, myotoxic and others (if any).

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in cryptosporidium diagnostic testing market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The cryptosporidium diagnostic testing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting cryptosporidium diagnostic testing market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the cryptosporidium diagnostic testing market in these regions.




Get more information on this report :

MARKET PLAYERS


The report covers key developments in the in cryptosporidium diagnostic testing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in cryptosporidium diagnostic testing market are anticipated to have lucrative growth opportunities in the future with the rising demand for in cryptosporidium diagnostic testing market in the global market. Below mentioned is the list of few companies engaged in the cryptosporidium diagnostic testing market.

The report also includes the profiles of key in cryptosporidium diagnostic testing market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Abbott
- Becton, Dickinson and Company,
- bioMérieux SA
- Bio-Rad Laboratories, Inc.
- Cepheid, Inc.
- DiaSorin
- ELITechGroup
- Enzo Biochem Inc.
- Fujirebio
- Grifols, S.A.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Cryptosporidium Diagnostic Testing Market - By Type
1.3.2 Cryptosporidium Diagnostic Testing Market - By Application
1.3.3 Cryptosporidium Diagnostic Testing Market - By Mode of Action
1.3.4 Cryptosporidium Diagnostic Testing Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CRYPTOSPORIDIUM DIAGNOSTIC TESTING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CRYPTOSPORIDIUM DIAGNOSTIC TESTING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. CRYPTOSPORIDIUM DIAGNOSTIC TESTING MARKET - GLOBAL MARKET ANALYSIS
6.1. CRYPTOSPORIDIUM DIAGNOSTIC TESTING - GLOBAL MARKET OVERVIEW
6.2. CRYPTOSPORIDIUM DIAGNOSTIC TESTING - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. CRYPTOSPORIDIUM DIAGNOSTIC TESTING MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. ACID-STAINING TEST
7.3.1. Overview
7.3.2. Acid-staining Test Market Forecast and Analysis
7.4. STOOL CULTURE
7.4.1. Overview
7.4.2. Stool Culture Market Forecast and Analysis
7.5. OTHERS
7.5.1. Overview
7.5.2. Others Market Forecast and Analysis
8. CRYPTOSPORIDIUM DIAGNOSTIC TESTING MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. COMMERCIAL AND PRIVATE LABS
8.4.1. Overview
8.4.2. Commercial and Private Labs Market Forecast and Analysis
8.5. PHYSICIAN OFFICES
8.5.1. Overview
8.5.2. Physician Offices Market Forecast and Analysis
8.6. PUBLIC HEALTH LABS
8.6.1. Overview
8.6.2. Public Health Labs Market Forecast and Analysis
9. CRYPTOSPORIDIUM DIAGNOSTIC TESTING MARKET - REVENUE AND FORECASTS TO 2027 - MODE OF ACTION
9.1. OVERVIEW
9.2. MODE OF ACTION MARKET FORECASTS AND ANALYSIS
9.3. CYTOTOXIC
9.3.1. Overview
9.3.2. Cytotoxic Market Forecast and Analysis
9.4. NEUROTOXIC
9.4.1. Overview
9.4.2. Neurotoxic Market Forecast and Analysis
9.5. HAEMOTOXIC
9.5.1. Overview
9.5.2. Haemotoxic Market Forecast and Analysis
9.6. CARDIOTOXIC
9.6.1. Overview
9.6.2. Cardiotoxic Market Forecast and Analysis
9.7. MYOTOXIC
9.7.1. Overview
9.7.2. Myotoxic Market Forecast and Analysis
9.8. OTHERS (IF ANY)
9.8.1. Overview
9.8.2. Others (If Any) Market Forecast and Analysis
10. CRYPTOSPORIDIUM DIAGNOSTIC TESTING MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Cryptosporidium Diagnostic Testing Market Overview
10.1.2 North America Cryptosporidium Diagnostic Testing Market Forecasts and Analysis
10.1.3 North America Cryptosporidium Diagnostic Testing Market Forecasts and Analysis - By Type
10.1.4 North America Cryptosporidium Diagnostic Testing Market Forecasts and Analysis - By Application
10.1.5 North America Cryptosporidium Diagnostic Testing Market Forecasts and Analysis - By Mode of Action
10.1.6 North America Cryptosporidium Diagnostic Testing Market Forecasts and Analysis - By Countries
10.1.6.1 United States Cryptosporidium Diagnostic Testing Market
10.1.6.1.1 United States Cryptosporidium Diagnostic Testing Market by Type
10.1.6.1.2 United States Cryptosporidium Diagnostic Testing Market by Application
10.1.6.1.3 United States Cryptosporidium Diagnostic Testing Market by Mode of Action
10.1.6.2 Canada Cryptosporidium Diagnostic Testing Market
10.1.6.2.1 Canada Cryptosporidium Diagnostic Testing Market by Type
10.1.6.2.2 Canada Cryptosporidium Diagnostic Testing Market by Application
10.1.6.2.3 Canada Cryptosporidium Diagnostic Testing Market by Mode of Action
10.1.6.3 Mexico Cryptosporidium Diagnostic Testing Market
10.1.6.3.1 Mexico Cryptosporidium Diagnostic Testing Market by Type
10.1.6.3.2 Mexico Cryptosporidium Diagnostic Testing Market by Application
10.1.6.3.3 Mexico Cryptosporidium Diagnostic Testing Market by Mode of Action
10.2. EUROPE
10.2.1 Europe Cryptosporidium Diagnostic Testing Market Overview
10.2.2 Europe Cryptosporidium Diagnostic Testing Market Forecasts and Analysis
10.2.3 Europe Cryptosporidium Diagnostic Testing Market Forecasts and Analysis - By Type
10.2.4 Europe Cryptosporidium Diagnostic Testing Market Forecasts and Analysis - By Application
10.2.5 Europe Cryptosporidium Diagnostic Testing Market Forecasts and Analysis - By Mode of Action
10.2.6 Europe Cryptosporidium Diagnostic Testing Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Cryptosporidium Diagnostic Testing Market
10.2.6.1.1 Germany Cryptosporidium Diagnostic Testing Market by Type
10.2.6.1.2 Germany Cryptosporidium Diagnostic Testing Market by Application
10.2.6.1.3 Germany Cryptosporidium Diagnostic Testing Market by Mode of Action
10.2.6.2 France Cryptosporidium Diagnostic Testing Market
10.2.6.2.1 France Cryptosporidium Diagnostic Testing Market by Type
10.2.6.2.2 France Cryptosporidium Diagnostic Testing Market by Application
10.2.6.2.3 France Cryptosporidium Diagnostic Testing Market by Mode of Action
10.2.6.3 Italy Cryptosporidium Diagnostic Testing Market
10.2.6.3.1 Italy Cryptosporidium Diagnostic Testing Market by Type
10.2.6.3.2 Italy Cryptosporidium Diagnostic Testing Market by Application
10.2.6.3.3 Italy Cryptosporidium Diagnostic Testing Market by Mode of Action
10.2.6.4 Spain Cryptosporidium Diagnostic Testing Market
10.2.6.4.1 Spain Cryptosporidium Diagnostic Testing Market by Type
10.2.6.4.2 Spain Cryptosporidium Diagnostic Testing Market by Application
10.2.6.4.3 Spain Cryptosporidium Diagnostic Testing Market by Mode of Action
10.2.6.5 United Kingdom Cryptosporidium Diagnostic Testing Market
10.2.6.5.1 United Kingdom Cryptosporidium Diagnostic Testing Market by Type
10.2.6.5.2 United Kingdom Cryptosporidium Diagnostic Testing Market by Application
10.2.6.5.3 United Kingdom Cryptosporidium Diagnostic Testing Market by Mode of Action
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Cryptosporidium Diagnostic Testing Market Overview
10.3.2 Asia-Pacific Cryptosporidium Diagnostic Testing Market Forecasts and Analysis
10.3.3 Asia-Pacific Cryptosporidium Diagnostic Testing Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Cryptosporidium Diagnostic Testing Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Cryptosporidium Diagnostic Testing Market Forecasts and Analysis - By Mode of Action
10.3.6 Asia-Pacific Cryptosporidium Diagnostic Testing Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Cryptosporidium Diagnostic Testing Market
10.3.6.1.1 Australia Cryptosporidium Diagnostic Testing Market by Type
10.3.6.1.2 Australia Cryptosporidium Diagnostic Testing Market by Application
10.3.6.1.3 Australia Cryptosporidium Diagnostic Testing Market by Mode of Action
10.3.6.2 China Cryptosporidium Diagnostic Testing Market
10.3.6.2.1 China Cryptosporidium Diagnostic Testing Market by Type
10.3.6.2.2 China Cryptosporidium Diagnostic Testing Market by Application
10.3.6.2.3 China Cryptosporidium Diagnostic Testing Market by Mode of Action
10.3.6.3 India Cryptosporidium Diagnostic Testing Market
10.3.6.3.1 India Cryptosporidium Diagnostic Testing Market by Type
10.3.6.3.2 India Cryptosporidium Diagnostic Testing Market by Application
10.3.6.3.3 India Cryptosporidium Diagnostic Testing Market by Mode of Action
10.3.6.4 Japan Cryptosporidium Diagnostic Testing Market
10.3.6.4.1 Japan Cryptosporidium Diagnostic Testing Market by Type
10.3.6.4.2 Japan Cryptosporidium Diagnostic Testing Market by Application
10.3.6.4.3 Japan Cryptosporidium Diagnostic Testing Market by Mode of Action
10.3.6.5 South Korea Cryptosporidium Diagnostic Testing Market
10.3.6.5.1 South Korea Cryptosporidium Diagnostic Testing Market by Type
10.3.6.5.2 South Korea Cryptosporidium Diagnostic Testing Market by Application
10.3.6.5.3 South Korea Cryptosporidium Diagnostic Testing Market by Mode of Action
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Cryptosporidium Diagnostic Testing Market Overview
10.4.2 Middle East and Africa Cryptosporidium Diagnostic Testing Market Forecasts and Analysis
10.4.3 Middle East and Africa Cryptosporidium Diagnostic Testing Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Cryptosporidium Diagnostic Testing Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Cryptosporidium Diagnostic Testing Market Forecasts and Analysis - By Mode of Action
10.4.6 Middle East and Africa Cryptosporidium Diagnostic Testing Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Cryptosporidium Diagnostic Testing Market
10.4.6.1.1 South Africa Cryptosporidium Diagnostic Testing Market by Type
10.4.6.1.2 South Africa Cryptosporidium Diagnostic Testing Market by Application
10.4.6.1.3 South Africa Cryptosporidium Diagnostic Testing Market by Mode of Action
10.4.6.2 Saudi Arabia Cryptosporidium Diagnostic Testing Market
10.4.6.2.1 Saudi Arabia Cryptosporidium Diagnostic Testing Market by Type
10.4.6.2.2 Saudi Arabia Cryptosporidium Diagnostic Testing Market by Application
10.4.6.2.3 Saudi Arabia Cryptosporidium Diagnostic Testing Market by Mode of Action
10.4.6.3 U.A.E Cryptosporidium Diagnostic Testing Market
10.4.6.3.1 U.A.E Cryptosporidium Diagnostic Testing Market by Type
10.4.6.3.2 U.A.E Cryptosporidium Diagnostic Testing Market by Application
10.4.6.3.3 U.A.E Cryptosporidium Diagnostic Testing Market by Mode of Action
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Cryptosporidium Diagnostic Testing Market Overview
10.5.2 South and Central America Cryptosporidium Diagnostic Testing Market Forecasts and Analysis
10.5.3 South and Central America Cryptosporidium Diagnostic Testing Market Forecasts and Analysis - By Type
10.5.4 South and Central America Cryptosporidium Diagnostic Testing Market Forecasts and Analysis - By Application
10.5.5 South and Central America Cryptosporidium Diagnostic Testing Market Forecasts and Analysis - By Mode of Action
10.5.6 South and Central America Cryptosporidium Diagnostic Testing Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Cryptosporidium Diagnostic Testing Market
10.5.6.1.1 Brazil Cryptosporidium Diagnostic Testing Market by Type
10.5.6.1.2 Brazil Cryptosporidium Diagnostic Testing Market by Application
10.5.6.1.3 Brazil Cryptosporidium Diagnostic Testing Market by Mode of Action
10.5.6.2 Argentina Cryptosporidium Diagnostic Testing Market
10.5.6.2.1 Argentina Cryptosporidium Diagnostic Testing Market by Type
10.5.6.2.2 Argentina Cryptosporidium Diagnostic Testing Market by Application
10.5.6.2.3 Argentina Cryptosporidium Diagnostic Testing Market by Mode of Action
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. CRYPTOSPORIDIUM DIAGNOSTIC TESTING MARKET, KEY COMPANY PROFILES
12.1. ABBOTT
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BECTON, DICKINSON AND COMPANY,
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. BIOMéRIEUX SA
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BIO-RAD LABORATORIES, INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. CEPHEID, INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. DIASORIN
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ELITECHGROUP
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. ENZO BIOCHEM INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. FUJIREBIO
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. GRIFOLS, S.A.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Abbott
2. Becton, Dickinson and Company,
3. bioMérieux SA
4. Bio-Rad Laboratories, Inc.
5. Cepheid, Inc.
6. DiaSorin
7. ELITechGroup
8. Enzo Biochem Inc.
9. Fujirebio
10. Grifols, S.A.
TIPRE00008503
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking